EurekaMag
+ Translate
+ Most Popular
The pigeon tick (Argas reflexus): its biology, ecology, and epidemiological aspects
Prevalence of hemoglobin abnormalities in Kebili (Tunisian South)
Lipogranuloma: a preventable complication of dacryocystorhinostomy
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
Bees from the Belgian Congo. The acraensis group of Anthophora
Placing gingival retraction cord
Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children
Acariens plumicoles Analgesoidea parasites des oiseaux du Maroc
Injuries of terminal phalanges of the fingers in children
Biology of flowering and nectar production in pear (Pyrus communis)
Das Reliktvorkommen der Aspisviper (Vipera aspis L.) im Schwarzwald
Hydrological modelling of drained blanket peatland
Pathologic morphology and clinical significance of the anomalous origin of the left circumflex coronary artery from the right coronary artery. General review and autopsy analysis of 30 cases
Cyto genetic analyses of lymphocyte cultures after exposure to calcium cyclamate
Axelrodia riesei, a new characoid fish from Upper Rio Meta in Colombia With remarks concerning the genus Axelrodia and description of a similar, sympatric, Hyphessobrycon-species
Favorable evolution of a case of tuberculosis of pancreas under antibiotic action
RIFM fragrance ingredient safety assessment, Valencene, CAS Registry Number 4630-07-3
Parenteral microemulsions: an overview
Temperate pasture: management for grazing and conservation
Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation
Thermal expansion and cracking of three confined water-saturated igneous rocks to 800C
Revision of the genera of the tribe Stigmoderini (Coleoptera: Buprestidae) a discussion of phylogenetic relationships
Anal tuberculosis. Report of a case
Gastric tuberculosis in the past and present
Adaptive responses of the cardiovascular system to prolonged spaceflight conditions: assessment with Holter monitoring

Peptide immunotherapy in experimental autoimmune encephalomyelitis


Peptide immunotherapy in experimental autoimmune encephalomyelitis



Biomedical Journal 38(3): 206-214



ISSN/ISBN: 2319-4170

PMID: 26068029

We now have potent drugs available to treat the inflammatory component of multiple sclerosis (MS). However, not all patients respond, the drugs are not curative, and the associated risks to beneficial immune surveillance are considerable. A more desirable approach is to specifically target those comparatively rare T lymphocytes that are orchestrating the autoimmune attack. Using the autoantigen itself to instill immune tolerance in those cells remains a holy grail of immunotherapy. Peptide immunotherapy (PIT) is highly effective at silencing autoimmune responses in experimental autoimmune encephalomyelitis (EAE), and clinical trials of PIT are underway in MS. This review discusses the current paradigms for PIT-induced tolerance in naïve T cells. It highlights the need for better understanding of the mode of action of PIT upon memory and effector T cells that are responsible for driving/sustaining ongoing autoimmune pathology. Recent studies in EAEsuggest genetic and epigenetic changes in these pathogenic T-cell populations in response to PIT. Finally, future challenges to effective translation of PIT to the clinic are considered.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058522820

Download citation: RISBibTeXText

Related references

Peptide mediated immunotherapy in experimental autoimmune encephalomyelitis. Journal of Cellular Biochemistry Suppl (15 Part A): 286, 1991

Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis. European Journal of Immunology 37(12): 3576-3581, 2007

Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases. FASEB Journal 5(11): 2560-2566, 1991

The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease. Harefuah 123(3-4): 110-115, 1992

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59(2): 247-255, 1989

Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses. American Journal of Pathology 168(4): 1179-1188, 2006

A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis. Journal of Immunology 161(1): 60-64, 1998

T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis. ImmunoTherapy 2(1): 99-115, 2010

Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. Journal of Immunology 167(4): 2379-2387, 2001

Regulation of experimental autoimmune encephalomyelitis: inhibition of adoptive experimental autoimmune encephalomyelitis by 'recovery-associated suppressor cells'. Journal of Neuroimmunology 53(2): 123-131, 1994

Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats. Biochemical and Biophysical Research Communications 443(3): 1118-1123, 2014

Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development. Journal of Neuroimmune Pharmacology: the Official Journal of the Society on Neuroimmune Pharmacology 5(2): 220-230, 2010

Treatment of MBP plus MOG-induced experimental autoimmune encephalomyelitis with a peptide of MBP. Journal of Allergy and Clinical Immunology 99(1 Part 2): S384, 1997

Autoantigenic peptide therapy in experimental autoimmune encephalomyelitis. Immunology Series 59: 345-357, 1993

Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clinical and Experimental Immunology 178(3): 447-458, 2014